Sonographic Follow up in Newborns Diagnosed With Prenatal Hydronephrosis
NCT ID: NCT01780103
Last Updated: 2013-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
143 participants
OBSERVATIONAL
2013-01-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These babies underwent renal sonography at the age of 2-5 days according to the protocol and were invited to an additional renal sonographic screening test at the age of 1 month.
The investigators will compare the results of the 2 examinations and the investigators will try to reach conclusions whether there is correspondence between the severity of the pyelectasis in the first and second sonographic tests and the outcome of these newborn babies
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasonography Sensibilized by Oral Hydration and Hydronephrosis in Children.
NCT02086760
Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
NCT04735315
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
NCT01349244
Clinical Significance of Supranormal Differential Renal Function in the Recovery of Hydronephrosis
NCT01839006
Minimizing the Utilization of Voiding Cystourethrography for Patients With Antenatal Hydronephrosis
NCT02825485
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Month
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Sylvia Foldi
Neonatologist MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYMC-0055-12-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.